Bimekizumab Efficacy and Safety in Patients With Psoriatic Arthritis Who Had Skin and Nail Psoriasis at Baseline: Up to 2-year Results From Two Phase 3 Studies. J of Skin. 2024;8(6):s435. doi:10.25251/skin.8.supp.435